109 related articles for article (PubMed ID: 28420060)
1. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.
Park DJ; Kang JH; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee SS
Lupus; 2017 Oct; 26(11):1139-1148. PubMed ID: 28420060
[TBL] [Abstract][Full Text] [Related]
2. Histologic versus clinical remission in proliferative lupus nephritis.
Malvar A; Pirruccio P; Alberton V; Lococo B; Recalde C; Fazini B; Nagaraja H; Indrakanti D; Rovin BH
Nephrol Dial Transplant; 2017 Aug; 32(8):1338-1344. PubMed ID: 26250434
[TBL] [Abstract][Full Text] [Related]
3. Combination of anti-SSA/Ro60 and anti-dsDNA serotype is predictive of belimumab renal response in patients with lupus nephritis.
Zhao L; Wang W; Wu L; Wu T; Tu J; Wu X; Sun F; Ding H; Shen N; Wu H; Zhu J; Sun L; Ye S
Lupus Sci Med; 2024 May; 11(1):. PubMed ID: 38806217
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease: the missing concept in the 2019 EULAR/ERA-EDTA recommendations for lupus nephritis.
Rojas-Rivera JE; Bakkaloglu SA; Bolignano D; Nistor I; Sarafidis PA; Stoumpos S; Cozzolino MG; Ortiz A
Nephrol Dial Transplant; 2023 Dec; 39(1):151-158. PubMed ID: 37433583
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of ISN/RPS classification of lupus nephritis.
Sada KE; Makino H
J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S7-10. PubMed ID: 19194566
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological characteristics and outcomes of lupus nephritis patients with scanty immune depositions in kidney biopsies.
Fan Y; Kang D; Chen Z; Lu Y; Huang X; Xia X; Chen W
J Nephrol; 2023 Nov; 36(8):2345-2354. PubMed ID: 37341964
[TBL] [Abstract][Full Text] [Related]
7. Predictors of renal relapse in Koreans with lupus nephritis after achieving complete response: a 35-years of experience at a single center.
Jeon H; Lee J; Moon SJ; Kwok SK; Ju JH; Kim WU; Park SH
Korean J Intern Med; 2024 Mar; 39(2):347-359. PubMed ID: 38247126
[TBL] [Abstract][Full Text] [Related]
8. Glomerular disease: perspectives on maintenance therapy in lupus nephritis.
Balow JE
Nat Rev Nephrol; 2012 Feb; 8(3):136-8. PubMed ID: 22310950
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of renal vascular lesions among patients with lupus nephritis: An experience from a tertiary care center.
Paul M; Addya S; Sengupta M; Basu K; Roychowdhury A; Bandopadhyay M
Indian J Pathol Microbiol; 2023; 66(4):751-757. PubMed ID: 38084527
[TBL] [Abstract][Full Text] [Related]
10. Risk of chronic kidney disease in 260 patients with lupus nephritis-analysis of a nationwide multicentre cohort with up to 35 years of follow-up.
Farinha F; Barreira S; Couto M; Cunha M; Fonseca D; Freitas R; Inês L; Luís M; Macieira C; Prata AR; Rodrigues J; Santos B; Torres R; Pepper RJ; Rahman A; Santos MJ
Rheumatology (Oxford); 2024 Apr; ():. PubMed ID: 38648778
[TBL] [Abstract][Full Text] [Related]
11. Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial.
Rovin BH; Furie RA; Ross Terres JA; Giang S; Schindler T; Turchetta A; Garg JP; Pendergraft WF; Malvar A
Arthritis Rheumatol; 2024 Feb; 76(2):247-254. PubMed ID: 37947366
[TBL] [Abstract][Full Text] [Related]
12. A nomogram predicting the histologic activity of lupus nephritis from clinical parameters.
Gao C; Bian X; Wu L; Zhan Q; Yu F; Pan H; Han F; Wang YF; Yang Y
Nephrol Dial Transplant; 2024 Feb; 39(3):520-530. PubMed ID: 37667508
[TBL] [Abstract][Full Text] [Related]
13. Infliximab biosimilar-induced lupus nephritis: A case report.
Shidahara K; Katsuyama T; Hirose K; Matsumoto K; Nawachi S; Nakadoi T; Asano Y; Katayama Y; Miyawaki Y; Katsuyama E; Takano-Narazaki M; Matsumoto Y; Sada KE; Wada J
Mod Rheumatol Case Rep; 2023 Dec; 8(1):74-76. PubMed ID: 37902434
[TBL] [Abstract][Full Text] [Related]
14. Extracellular mitochondrial components as new biomarkers for lupus nephritis.
Gowda S; Rana K; Kumar A; Prajapati PK; Patel N; Pandya S; Srivastava R
Lupus; 2024 Jul; 33(8):779-786. PubMed ID: 38621786
[TBL] [Abstract][Full Text] [Related]
15. Consensus document of the Spanish Group for the Study of the Glomerular Diseases (GLOSEN) for the diagnosis and treatment of lupus nephritis.
Rojas-Rivera JE; García-Carro C; Ávila AI; Espino M; Espinosa M; Fernández-Juárez G; Fulladosa X; Goicoechea M; Macía M; Morales E; Porras LFQ; Praga M
Nefrologia (Engl Ed); 2023; 43(1):6-47. PubMed ID: 37211521
[TBL] [Abstract][Full Text] [Related]
16. Long-term outcomes and associated prognostic risk factors of childhood-onset lupus nephritis.
Park E; Jung J; Min J; Lee H; Park MJ; Song JY; Kim JH; Jang KM; Yang EM; Ahn YH; Cho MH; Lee JH; Park YS; Kim SC; Park SJ; Lee JW; Kim KH; Pai KS; Kang HG; Kim SH
Kidney Res Clin Pract; 2023 Dec; ():. PubMed ID: 38148127
[TBL] [Abstract][Full Text] [Related]
17. Development of clinical and laboratory biomarkers in an international cohort of 428 children with lupus nephritis.
De Mutiis C; Wenderfer SE; Basu B; Bagga A; Orjuela A; Sar T; Aggarwal A; Jain A; Boyer O; Yap HK; Ito S; Ohnishi A; Iwata N; Kasapcopur O; Laurent A; Chan EY; Mastrangelo A; Ogura M; Shima Y; Rianthavorn P; Silva CA; Trindade V; Tullus K
Pediatr Nephrol; 2024 May; ():. PubMed ID: 38802607
[TBL] [Abstract][Full Text] [Related]
18. Risk stratification for infection during immunosuppressive therapy in patients with lupus nephritis: A nested case-control study.
Lu J; Wu Y; Xue J; Hao C
Lupus; 2024 Jul; 33(8):828-839. PubMed ID: 38662532
[TBL] [Abstract][Full Text] [Related]
19. Kidney Biopsy in Management of Lupus Nephritis: A Case-Based Narrative Review.
Rodriguez-Ramirez S; Wiegley N; Mejia-Vilet JM
Kidney Med; 2024 Feb; 6(2):100772. PubMed ID: 38317756
[TBL] [Abstract][Full Text] [Related]
20. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis.
Rovin BH; Ayoub IM; Chan TM; Liu ZH; Mejía-Vilet JM; Balk EM; Gordon CE; Adam G; Tonelli MA; Cheung M; Earley A; Floege J
Kidney Int; 2024 Jan; 105(1):31-34. PubMed ID: 38182299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
